Diet, microbial virulence and Helicobacter pylori-induced gastric cancer

Gut Microbes

Volumn 4, Issue 6, 2013, Pages

  Cover, Timothy L ^a,b   Peek Jr , Richard M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Veteran's Affairs Tennessee Valley Healthcare System   (United States)

Author keywords

BabA; Cag pathogenicity island; CagA; Diet; Gastric adenocarcinoma; Gastric cancer; Iron; Salt; VacA

Indexed keywords

BETA CATENIN; CAGA PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 8; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; IRON; SODIUM CHLORIDE; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; CANCER INCIDENCE; CANCER RISK; CELL PROLIFERATION; CHOLESTEROL INTAKE; DIET; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HELICOBACTER INFECTION; HISTOLOGY; HUMAN; INFECTION CONTROL; INFECTION RISK; IRON DEFICIENCY ANEMIA; IRON INTAKE; NONHUMAN; PREVALENCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SALT INTAKE; STOMACH CANCER; TOBACCO; UPREGULATION; ANIMAL; BABA; BLOOD; CAGA; CAGPATHOGENICITY ISLAND; DISEASE MODEL; GENETICS; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; META ANALYSIS (TOPIC); MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; RISK FACTOR; SMOKING; SODIUM INTAKE; STOMACH ADENOCARCINOMA; STOMACH TUMOR; VACA; VIRULENCE;

BABA; CAGA; CAGPATHOGENICITY ISLAND; DIET; GASTRIC ADENOCARCINOMA; GASTRIC CANCER; IRON; SALT; VACA;

ANEMIA, IRON-DEFICIENCY; ANIMALS; CHOLESTEROL, DIETARY; DIET; DISEASE MODELS, ANIMAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; IRON; META-ANALYSIS AS TOPIC; RISK FACTORS; SMOKING; SODIUM, DIETARY; STOMACH NEOPLASMS; VIRULENCE; VIRULENCE FACTORS;

EID: 84887920953     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.26262     Document Type: Review

References (148)

1. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333:32-41 PMID:7776992 http://dx.doi.org/10.1056/NEJM199507063330107
2. de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13:607-15 PMID:22575588 http://dx.doi.org/10.1016/S1470-2045(12)70137-7
3. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49:1374-403 PMID:23485231 http://dx.doi.org/10.1016/j.ejca.2012.12.027
4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108 PMID:15761078 http://dx.doi.org/10.3322/canj-clin.55.2.74
5. Correa P. Human gastric carcinogenesis: a multi-step and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52:6735-40 PMID:1458460
6. Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 2012; 380:1840-50 PMID:23079588 http://dx.doi.org/10.1016/S0140-6736(12)60919-2
7. Forman D, Pisani P. Gastric cancer in Japan-honing treatment, seeking causes. N Engl J Med 2008; 359:448-51 PMID:18669423 http://dx.doi.org/10.1056/NEJMp0804354
8. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8:1-27 PMID:3533579
9. Sonnenberg A. Differences in the birth-cohort patterns of gastric cancer and peptic ulcer. Gut 2010; 59:736-43 PMID:20551458 http://dx.doi.org/10.1136/gut.2009.195008
10. Haile RW, John EM, Levine AJ, Cortessis VK, Unger JB, Gonzales M, Ziv E, Thompson P, Spruijt-Metz D, Tucker KL, et al. A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila) 2012; 5:150-63 PMID:22307564 http://dx.doi.org/10.1158/1940-6207.CAPR-11-0447
11. Wu X, Chen VW, Andrews PA, Ruiz B, Correa P. Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control 2007; 18:585-93 PMID:17406989 http://dx.doi.org/10.1007/s10552-007-9000-1
12. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287-9 PMID:1995976 http://dx.doi.org/10.1001/jama.1991.03460100089030
13. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104:510-3 PMID:8425693
14. Correa P, Cuello C, Duque E, Burbano LC, Garcia FT, Bolanos O, Brown C, Haenszel W. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 1976; 57:1027-35 PMID:1003539
15. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1:1311-5 PMID:6145023 http://dx.doi.org/10.1016/S0140-6736(84)91816-6
16. Polk DB, Peek RM Jr. Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 2010; 10:403-14 PMID:20495574 http://dx.doi.org/10.1038/nrc2857
17. Fox JG, Wang TC. Inflammation, atrophy, and gastric cancer. J Clin Invest 2007; 117:60-9 PMID:17200707 http://dx.doi.org/10.1172/JCI30111
18. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology 2009; 136:1863-73 PMID:19457415 http://dx.doi.org/10.1053/j.gas-tro.2009.01.073
19. Atherton JC, Blaser MJ. Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 2009; 119:2475-87 PMID:19729845 http://dx.doi.org/10.1172/JCI38605
20. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 2000; 22:283-97 PMID:11218379 http://dx.doi.org/10.1093/oxfordjournals.epirev.a018040
21. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341:1359-62 PMID:8098787 http://dx.doi.org/10.1016/0140-6736(93)90938-D
22. Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114:1169-79 PMID:9609753 http://dx.doi.org/10.1016/S0016-5085(98)70422-6
23. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, Abnet CC, Albanes D, Virtamo J, Taylor PR. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 2006; 98:1445-52 PMID:17047193 http://dx.doi.org/10.1093/jnci/djj393
24. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-9 PMID:11556297 http://dx.doi.org/10.1056/NEJMoa001999
25. Nomura A, Stemmermann GN, Chyou PH, Kato I, Pérez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325:1132-6 PMID:1891021 http://dx.doi.org/10.1056/NEJM199110173251604
26. Parsonnet J, Friedman GD, Vandersteen D P, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-31 PMID:1891020 http://dx.doi.org/10.1056/NEJM199110173251603
27. Dooley C P, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1989; 321:1562-6 PMID:2586553 http://dx.doi.org/10.1056/NEJM198912073212302
28. Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 2008; 134:306-23 PMID:18166359 http://dx.doi.org/10.1053/j.gastro.2007.11.009
29. Atherton JC. The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu Rev Pathol 2006; 1:63-96 PMID:18039108 http://dx.doi.org/10.1146/annurev.pathol.1.110304.100125
30. Peek RM Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer 2002; 2:28-37 PMID:11902583 http://dx.doi.org/10.1038/nrc703
31. Blaser MJ, Berg DE. Helicobacter pylori genetic diversity and risk of human disease. J Clin Invest 2001; 107:767-73 PMID:11285290 http://dx.doi.org/10.1172/JCI12672
32. Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, Rappuoli R, Covacci A. cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A 1996; 93:14648-53 PMID:8962108 http://dx.doi.org/10.1073/pnas.93.25.14648
33. Akopyants NS, Clifton S W, Kersulyte D, Crabtree JE, Youree BE, Reece CA, Bukanov NO, Drazek ES, Roe BA, Berg DE. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol Microbiol 1998; 28:37-53 PMID:9593295 http://dx.doi.org/10.1046/j.1365-2958.1998.00770.x
34. Olbermann P, Josenhans C, Moodley Y, Uhr M, Stamer C, Vauterin M, Suerbaum S, Achtman M, Linz B. A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet 2010; 6:e1001069 PMID:20808891 http://dx.doi.org/10.1371/journal.pgen.1001069
35. Odenbreit S, Püls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000; 287:1497-500 PMID:10688800 http://dx.doi.org/10.1126/science.287.5457.1497
36. Fischer W, Püls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Mol Microbiol 2001; 42:1337-48 PMID:11886563 http://dx.doi.org/10.1046/j.1365-2958.2001.02714.x
37. Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, Misselwitz R, Berger J, Sewald N, König W, et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 2007; 449:862-6 PMID:17943123 http://dx.doi.org/10.1038/nature06187
38. Shaffer CL, Gaddy JA, Loh JT, Johnson EM, Hill S, Hennig EE, McClain MS, McDonald WH, Cover TL. Helicobacter pylori exploits a unique repertoire of type IV secretion system components for pilus assembly at the bacteria-host cell interface. PLoS Pathog 2011; 7:e1002237 PMID:21909278 http://dx.doi.org/10.1371/journal.ppat.1002237
39. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-5 PMID:7743510
40. Nomura AM, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser MJ. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis 2002; 186:1138-44 PMID:12355365 http://dx.doi.org/10.1086/343808
41. Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, Wroblewski LE, Piazuelo MB, Correa P, Peek RM Jr. Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res 2008; 68:379-87 PMID:18199531 http://dx.doi.org/10.1158/0008-5472.CAN-07-0824
42. Gaddy JA, Radin JN, Loh JT, Zhang F, Washington MK, Peek RM Jr., Algood HM, Cover TL. High dietary salt intake exacerbates Helicobacter pylori-induced gastric carcinogenesis. Infect Immun 2013; 81:2258-67 PMID:23569116 http://dx.doi.org/10.1128/IAI.01271-12
43. Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S. c-Src and c-Abl kinases control hierarchic phos-phorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest 2012; 122:1553-66 PMID:22378042 http://dx.doi.org/10.1172/JCI61143
44. Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 2002; 295:683-6 PMID:11743164 http://dx.doi.org/10.1126/science.1067147
45. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, Ohnishi N, Azuma T, Suzuki A, et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007; 447:330-3 PMID:17507984 http://dx.doi.org/10.1038/nature05765
46. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 2003; 300:1430-4 PMID:12775840 http://dx.doi.org/10.1126/science.1081919
47. Franco AT, Israel DA, Washington MK, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Perez-Perez GI, Hatakeyama M, et al. Activation of β-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A 2005; 102:10646-51 PMID:16027366 http://dx.doi.org/10.1073/pnas.0504927102
48. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM Jr., Azuma T, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal trans-differentiation in gastric epithelial cells. Oncogene 2007; 26:4617-26 PMID:17237808 http://dx.doi.org/10.1038/sj.onc.1210251
49. Brandt S, Kwok T, Hartig R, König W, Backert S. NF-kappaB activation and potentiation of proinflam-matory responses by the Helicobacter pylori CagA protein. Proc Natl Acad Sci U S A 2005; 102:9300-5 PMID:15972330 http://dx.doi.org/10.1073/pnas.0409873102
50. Ohnishi N, Yuasa H, Tanaka S, Sawa H, Miura M, Matsui A, Higashi H, Musashi M, Iwabuchi K, Suzuki M, et al. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoi-etic neoplasms in mouse. Proc Natl Acad Sci U S A 2008; 105:1003-8 PMID:18192401 http://dx.doi.org/10.1073/pnas.0711183105
51. Hatakeyama M. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 2004; 4:688-94 PMID:15343275 http://dx.doi.org/10.1038/nrc1433
52. Cover TL, Blanke SR. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 2005; 3:320-32 PMID:15759043 http://dx.doi.org/10.1038/nrmicro1095
53. Boquet P, Ricci V. Intoxication strategy of Helicobacter pylori VacA toxin. Trends Microbiol 2012; 20:165-74 PMID:22364673 http://dx.doi.org/10.1016/j.tim.2012.01.008
54. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992; 267:10570-5 PMID:1587837
55. Gangwer KA, Mushrush DJ, Stauff DL, Spiller B, McClain MS, Cover TL, Lacy DB. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain. Proc Natl Acad Sci U S A 2007; 104:16293-8 PMID:17911250 http://dx.doi.org/10.1073/pnas.0707447104
56. Iwamoto H, Czajkowsky DM, Cover TL, Szabo G, Shao Z. VacA from Helicobacter pylori: a hexamer-ic chloride channel. FEBS Lett 1999; 450:101-4 PMID:10350065 http://dx.doi.org/10.1016/S0014-5793(99)00474-3
57. Szabò I, Brutsche S, Tombola F, Moschioni M, Satin B, Telford JL, Rappuoli R, Montecucco C, Papini E, Zoratti M. Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J 1999; 18:5517-27 PMID:10523296 http://dx.doi.org/10.1093/emboj/18.20.5517
58. McClain MS, Iwamoto H, Cao P, Vinion-Dubiel AD, Li Y, Szabo G, Shao Z, Cover TL. Essential role of a GXXXG motif for membrane channel formation by Helicobacter pylori vacuolating toxin. J Biol Chem 2003; 278:12101-8 PMID:12562777 http://dx.doi.org/10.1074/jbc.M212595200
59. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 2003; 301:1099-102 PMID:12934009 http://dx.doi.org/10.1126/science.1086871
60. Boncristiano M, Paccani SR, Barone S, Ulivieri C, Patrussi L, Ilver D, Amedei A, D'Elios MM, Telford JL, Baldari C T. The Helicobacter pylori vacu- olating toxin inhibits T cell activation by two inde pendent mechanisms. J Exp Med 2003; 198:1887-97 PMID:14676300 http://dx.doi.org/10.1084/jem.20030621
61. Sundrud MS, Torres VJ, Unutmaz D, Cover TL. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is inde pendent of VacA effects on IL-2 secretion. Proc Natl Acad Sci U S A 2004; 101:7727-32 PMID:15128946 http://dx.doi.org/10.1073/pnas.0401528101
62. Torres VJ, VanCompernolle SE, Sundrud MS, Unutmaz D, Cover TL. Helicobacter pylori vacuolating cytotoxin inhibits activation-induced proliferation of human T and B lymphocyte subsets. J Immunol 2007; 179:5433-40 PMID:17911630
63. Atherton JC, Cao P, Peek RM Jr., Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270:17771-7 PMID:7629077 http://dx.doi.org/10.1074/jbc.270.30.17771
64. Rhead JL, Letley D P, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC. A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology 2007; 133:926-36 PMID:17854597 http://dx.doi.org/10.1053/j.gastro.2007.06.056
65. Letley D P, Atherton JC. Natural diversity in the N terminus of the mature vacuolating cytotoxin of Helicobacter pylori determines cytotoxin activity. J Bacteriol 2000; 182:3278-80 PMID:10809711 http://dx.doi.org/10.1128/JB.182.11.3278-3280.2000
66. McClain MS, Cao P, Iwamoto H, Vinion-Dubiel AD, Szabo G, Shao Z, Cover TL. A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation. J Bacteriol 2001; 183:6499-508 PMID:11673417 http://dx.doi.org/10.1128/JB.183.22.6499-6508.2001
67. Pagliaccia C, de Bernard M, Lupetti P, Ji X, Burroni D, Cover TL, Papini E, Rappuoli R, Telford JL, Reyrat JM. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc Natl Acad Sci U S A 1998; 95:10212-7 PMID:9707626 http://dx.doi.org/10.1073/pnas.95.17.10212
68. González-Rivera C, Algood HM, Radin JN, McClain MS, Cover TL. The intermediate region of Helicobacter pylori VacA is a determinant of toxin potency in a Jurkat T cell assay. Infect Immun 2012; 80:2578-88 PMID:22585965 http://dx.doi.org/10.1128/IAI.00052-12
69. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha A F, Quint W, Caldas C, van Doorn LJ, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94:1680-7 PMID:12441323 http://dx.doi.org/10.1093/jnci/94.22.1680
70. Basso D, Zambon C F, Letley D P, Stranges A, Marchet A, Rhead JL, Schiavon S, Guariso G, Ceroti M, Nitti D, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 2008; 135:91-9 PMID:18474244 http://dx.doi.org/10.1053/j.gastro.2008.03.041
71. Miehlke S, Kirsch C, Agha-Amiri K, Günther T, Lehn N, Malfertheiner P, Stolte M, Ehninger G, Bayerdörffer E. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany. Int J Cancer 2000; 87:322-7 PMID:10897035 http://dx.doi.org/10.1002/1097-0215(20000801)87:3322::AID-IJC33.0.CO;2-M
72. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik E T, Berg DE, Covacci A, Engstrand L, Borén T. Helicobacter pylori adhesin binding fucosyl-ated histo-blood group antigens revealed by retagging. Science 1998; 279:373-7 PMID:9430586 http://dx.doi.org/10.1126/science.279.5349.373
73. Gerhard M, Lehn N, Neumayer N, Borén T, Rad R, Schepp W, Miehlke S, Classen M, Prinz C. Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A 1999; 96:12778-83 PMID:10535999 http://dx.doi.org/10.1073/pnas.96.22.12778
74. Oliveira AG, Santos A, Guerra JB, Rocha GA, Rocha AM, Oliveira CA, Cabral MM, Nogueira AM, Queiroz DM. babA2-and cagA-positive Helicobacter pylori strains are associated with duodenal ulcer and gastric carcinoma in Brazil. J Clin Microbiol 2003; 41:3964-6 PMID:12904430 http://dx.doi.org/10.1128/JCM.41.8.3964-3966.2003
75. Yu J, Leung WK, Go MY, Chan MC, To KF, Ng EK, Chan FK, Ling TK, Chung SC, Sung JJ. Relationship between Helicobacter pylori babA2 status with gastric epithelial cell turnover and premalignant gastric lesions. Gut 2002; 51:480-4 PMID:12235067 http://dx.doi.org/10.1136/gut.51.4.480
76. Hennig EE, Mernaugh R, Edl J, Cao P, Cover TL. Heterogeneity among Helicobacter pylori strains in expression of the outer membrane protein BabA. Infect Immun 2004; 72:3429-35 PMID:15155649 http://dx.doi.org/10.1128/IAI.72.6.3429-3435.2004
77. Ito Y, Azuma T, Ito S, Miyaji H, Hirai M, Yamazaki Y, Sato F, Kato T, Kohli Y, Kuriyama M. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 1997; 35:1710-4 PMID:9196179
78. Hatakeyama M. Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein. Cancer Sci 2011; 102:36-43 PMID:20942897 http://dx.doi.org/10.1111/j.1349-7006.2010.01743.x
79. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29:425-9 PMID:8036458 http://dx.doi.org/10.3109/00365529409096833
80. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothman N, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402 PMID:10746728 http://dx.doi.org/10.1038/35006081
81. Crabtree JE, Shallcross TM, Heatley RV, Wyatt JI. Mucosal tumour necrosis factor alpha and interleu-kin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991; 32:1473-7 PMID:1773951 http://dx.doi.org/10.1136/gut.32.12.1473
82. El-Omar EM, Rabkin CS, Gammon MD, Vaughan TL, Risch HA, Schoenberg JB, Stanford JL, Mayne ST, Goedert J, Blot WJ, et al. Increased risk of non-cardia gastric cancer associated with proinflamma-tory cytokine gene polymorphisms. Gastroenterology 2003; 124:1193-201 PMID:12730860 http://dx.doi.org/10.1016/S0016-5085(03)00157-4
83. Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, Peters MJ, Capelle LG, Zimmermann K, Rivadeneira F, Gruska S, et al. Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA 2013; 309:1912-20 PMID:23652523 http://dx.doi.org/10.1001/jama.2013.4350
84. Shikata K, Doi Y, Yonemoto K, Arima H, Ninomiya T, Kubo M, Tanizaki Y, Matsumoto T, Iida M, Kiyohara Y. Population-based prospective study of the combined influence of cigarette smoking and Helicobacter pylori infection on gastric cancer incidence: the Hisayama Study. Am J Epidemiol 2008; 168:1409-15 PMID:18945691 http://dx.doi.org/10.1093/aje/kwn276
85. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, Lunet N. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008; 19:689-701 PMID:18293090 http://dx.doi.org/10.1007/s10552-008-9132-y
86. Brenner H, Arndt V, Bode G, Stegmaier C, Ziegler H, Stümer T. Risk of gastric cancer among smokers infected with Helicobacter pylori. Int J Cancer 2002; 98:446-9 PMID:11920598 http://dx.doi.org/10.1002/ijc.10201
87. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007; 10:75-83 PMID:17577615 http://dx.doi.org/10.1007/s10120-007-0420-0
88. Epplein M, Nomura AM, Hankin JH, Blaser MJ, Perez-Perez G, Stemmermann GN, Wilkens LR, Kolonel LN. Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case-control study in Hawaii. Cancer Causes Control 2008; 19:869-77 PMID:18369531 http://dx.doi.org/10.1007/s10552-008-9149-2
89. González CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, Ferrari P, Boeing H, del Giudice G, Plebani M, et al. Meat intake and risk of stomach and esopha-geal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006; 98:345-54 PMID:16507831 http://dx.doi.org/10.1093/jnci/djj071
90. Gonzalez CA, Lujan-Barroso L, Bueno-de-Mesquita HB, Jenab M, Duell EJ, Agudo A, Tjønneland A, Boutron-Ruault MC, Clavel-Chapelon F, Touillaud M, et al. Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study after a longer follow-up. Int J Cancer 2012; 131:2910-9 PMID:22473701 http://dx.doi.org/10.1002/ijc.27565
91. Kim HJ, Lim SY, Lee JS, Park S, Shin A, Choi BY, Shimazu T, Inoue M, Tsugane S, Kim J. Fresh and pickled vegetable consumption and gastric cancer in Japanese and Korean populations: a meta-analysis of observational studies. Cancer Sci 2010; 101:508-16 PMID:19860848 http://dx.doi.org/10.1111/j.1349-7006.2009.01374.x
92. Ren JS, Kamangar F, Forman D, Islami F. Pickled food and risk of gastric cancer--a systematic review and meta-analysis of English and Chinese literature. Cancer Epidemiol Biomarkers Prev 2012; 21:905-15 PMID:22499775 http://dx.doi.org/10.1158/1055-9965.EPI-12-0202
93. Kim MK, Sasaki S, Sasazuki S, Tsugane S; Japan Public Health Center-based Prospective Study Group. Prospective study of three major dietary patterns and risk of gastric cancer in Japan. Int J Cancer 2004; 110:435-42 PMID:15095311 http://dx.doi.org/10.1002/ijc.20132
94. Lee SA, Kang D, Shim KN, Choe JW, Hong WS, Choi H. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 2003; 13:162-8 PMID:12749604 http://dx.doi.org/10.2188/jea.13.162
95. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005; 96:1-6 PMID:15649247 http://dx.doi.org/10.1111/j.1349-7006.2005.00006.x
96. Oiso T. Incidence of stomach cancer and its relation to dietary habits and nutrition in Japan between 1900 and 1975. Cancer Res 1975; 35:3254-8 PMID:1104142
97. You WC, Blot WJ, Chang YS, Ershow AG, Yang ZT, An Q, Henderson B, Xu GW, Fraumeni JF Jr., Wang TG. Diet and high risk of stomach cancer in Shandong, China. Cancer Res 1988; 48:3518-23 PMID:3370645
98. Joossens JV, Hill MJ, Elliott P, Stamler R, Lesaffre E, Dyer A, Nichols R, Kesteloot H; European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Dietary salt, nitrate and stomach cancer mortality in 24 countries. Int J Epidemiol 1996; 25:494-504 PMID:8671549 http://dx.doi.org/10.1093/ije/25.3.494
99. Chen VW, Abu-Elyazeed RR, Zavala DE, Ktsanes VK, Haenszel W, Cuello C, Montes G, Correa P. Risk factors of gastric precancerous lesions in a high-risk Colombian population. I. Salt. Nutr Cancer 1990; 13:59-65 PMID:2300494 http://dx.doi.org/10.1080/01635589009514045
100. Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, Shirota T, Tanizaki Y, Doi Y, Tanaka K, Oishi Y, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 2006; 119:196-201 PMID:16450397 http://dx.doi.org/10.1002/ijc.21822
101. Wiseman M. The second World Cancer Research Fund/American Institute for Cancer Research expert report. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008; 67:253-6 PMID:18452640 http://dx.doi.org/10.1017/S002966510800712X
102. Zhang Z, Xu G, Ma M, Yang J, Liu X. Dietary fiber intake reduces risk for gastric cancer: a meta-analysis. Gastroenterology 2013; 145:113-20 PMID:23567349 http://dx.doi.org/10.1053/j.gas-tro.2013.04.001
103. You WC, Zhang L, Gail MH, Chang YS, Liu WD, Ma JL, Li JY, Jin ML, Hu YR, Yang CS, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000; 92:1607-12 PMID:11018097 http://dx.doi.org/10.1093/jnci/92.19.1607
104. Jenab M, Riboli E, Ferrari P, Sabate J, Slimani N, Norat T, Friesen M, Tjønneland A, Olsen A, Overvad K, et al. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis 2006; 27:2250-7 PMID:16774936 http://dx.doi.org/10.1093/carcin/bgl096
105. Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, Scotti L, Islami F, Corrao G, La Vecchia C, Boffetta P. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol 2012; 23:28-36 PMID:21536659 http://dx.doi.org/10.1093/annonc/mdr135
106. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2003; 95:1784-91 PMID:14652240 http://dx.doi.org/10.1093/jnci/djg106
107. Correa P. Gastric cancer: overview. Gastroenterol Clin North Am 2013; 42:211-7 PMID:23639637 http://dx.doi.org/10.1016/j.gtc.2013.01.002
108. Nomura A, Chyou PH, Stemmermann GN. Association of serum ferritin levels with the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 1992; 1:547-50 PMID:1302566
109. Harrison LE, Zhang ZF, Karpeh MS, Sun M, Kurtz RC. The role of dietary factors in the intestinal and diffuse histologic subtypes of gastric adenocarcinoma: a case-control study in the U.S. Cancer 1997; 80:1021-1028.
110. Prá D, Rech Franke SI, Pegas Henriques JA, Fenech M. A possible link between iron deficiency and gastrointestinal carcinogenesis. Nutr Cancer 2009; 61:415-26 PMID:19838913 http://dx.doi.org/10.1080/01635580902803701
111. Akiba S, Neriishi K, Blot WJ, Kabuto M, Stevens RG, Kato H, Land CE. Serum ferritin and stomach cancer risk among a Japanese population. Cancer 1991; 67:1707-12 PMID:2001562 http://dx.doi.org/10.1002/1097-0142(19910315)67:61707::AID-CNCR28206706383.0.CO;2-C
112. van Lee L, Heyworth J, McNaughton S, Iacopetta B, Clayforth C, Fritschi L. Selected dietary micronu-trients and the risk of right- and left-sided colorectal cancers: a case-control study in Western Australia. Ann Epidemiol 2011; 21:170-7 PMID:21109455 http://dx.doi.org/10.1016/j.annepidem.2010.10.005
113. Ioannou GN, Rockey DC, Bryson CL, Weiss NS. Iron deficiency and gastrointestinal malignancy: a population-based cohort study. Am J Med 2002; 113:276-80 PMID:12361812 http://dx.doi.org/10.1016/S0002-9343(02)01214-7
114. Yip R, Limburg PJ, Ahlquist DA, Carpenter HA, O'Neill A, Kruse D, Stitham S, Gold BD, Gunter E W, Looker AC, et al. Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA 1997; 277:1135-9 PMID:9087468 http://dx.doi.org/10.1001/jama.1997.03540380049030
115. Waring AJ, Drake IM, Schorah CJ, White KL, Lynch DA, Axon AT, Dixon M F. Ascorbic acid and total vitamin C concentrations in plasma, gastric juice, and gastrointestinal mucosa: effects of gastritis and oral supplementation. Gut 1996; 38:171-6 PMID:8801192 http://dx.doi.org/10.1136/gut.38.2.171
116. Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliövaara M, Hakulinen T. Body iron stores and risk of cancer. Int J Cancer 1994; 56:379-82 PMID:8314326 http://dx.doi.org/10.1002/ijc.2910560315
117. Fox JG, Dangler CA, Taylor NS, King A, Koh TJ, Wang TC. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res 1999; 59:4823-8 PMID:10519391
118. Fox JG, Rogers AB, Ihrig M, Taylor NS, Whary MT, Dockray G, Varro A, Wang TC. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 2003; 63:942-50 PMID:12615707
119. Rogers AB, Taylor NS, Whary MT, Stefanich ED, Wang TC, Fox JG. Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res 2005; 65:10709-15 PMID:16322215 http://dx.doi.org/10.1158/0008-5472.CAN-05-1846
120. Gamboa-Dominguez A, Ubbelohde T, Saqui-Salces M, Romano-Mazzoti L, Cervantes M, Domínguez-Fonseca C, de la Luz Estreber M, Ruíz-Palacios GM. Salt and stress synergize H. pylori-induced gastric lesions, cell proliferation, and p21 expression in Mongolian gerbils. Dig Dis Sci 2007; 52:1517-26 PMID:17404882 http://dx.doi.org/10.1007/s10620-006-9524-3
121. Toyoda T, Tsukamoto T, Hirano N, Mizoshita T, Kato S, Takasu S, Ban H, Tatematsu M. Synergistic upregu-lation of inducible nitric oxide synthase and cyclooxy-genase-2 in gastric mucosa of Mongolian gerbils by a high-salt diet and Helicobacter pylori infection. Histol Histopathol 2008; 23:593-9 PMID:18283644
122. Bergin IL, Sheppard BJ, Fox JG. Helicobacter pylori infection and high dietary salt independently induce atrophic gastritis and intestinal metaplasia in commercially available outbred Mongolian gerbils. Dig Dis. Sci Mar 2003; 48:475-85
123. Nozaki K, Shimizu N, Inada K, Tsukamoto T, Inoue M, Kumagai T, Sugiyama A, Mizoshita T, Kaminishi M, Tatematsu M. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 2002; 93:1083-9 PMID:12417037 http://dx.doi.org/10.1111/j.1349-7006.2002.tb01209.x
124. Kato S, Tsukamoto T, Mizoshita T, Tanaka H, Kumagai T, Ota H, Katsuyama T, Asaka M, Tatematsu M. High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int J Cancer 2006; 119:1558-66 PMID:16646055 http://dx.doi.org/10.1002/ijc.21810
125. Jagadeesan V, Rao NJ, Sesikeran B. Effect of iron deficiency on DMH-induced gastrointestinal tract tumors and occurrence of hepatocyte abnormalities in Fischer rats. Nutr Cancer 1994; 22:285-91 PMID:7877898 http://dx.doi.org/10.1080/01635589409514354
126. Keenan JI, Peterson RA, Fraser R, Frampton CM, Walmsley TA, Allardyce RA, Roake JA. The effect of Helicobacter pylori infection and dietary iron deficiency on host iron homeostasis: a study in mice. Helicobacter 2004; 9:643-50 PMID:15610078 http://dx.doi.org/10.1111/j.1083-4389.2004.00278.x
127. Gobel R, Symonds EL, Kritas S, Butler RN, Tran CD. Helicobacter felis infection causes an acute iron deficiency in nonpregnant and pregnant mice. Helicobacter 2006; 11:529-32 PMID:17083374 http://dx.doi.org/10.1111/j.1523-5378.2006.00455.x
128. Thomson MJ, Pritchard DM, Boxall SA, Abuderman AA, Williams JM, Varro A, Crabtree JE. Gastric Helicobacter infection induces iron deficiency in the INS-GAS mouse. PLoS One 2012; 7:e50194 PMID:23185574 http://dx.doi.org/10.1371/journal. pone.0050194
129. Noto JM, Gaddy JA, Lee JY, Piazuelo MB, Friedman DB, Colvin DC, Romero-Gallo J, Suarez G, Loh J, Slaughter JC, et al. Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest 2013; 123:479-92 PMID:23257361 http://dx.doi.org/10.1172/JCI64373
130. Wunder C, Churin Y, Winau F, Warnecke D, Vieth M, Lindner B, Zähringer U, Mollenkopf HJ, Heinz E, Meyer T F. Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med 2006; 12:1030-8 PMID:16951684 http://dx.doi.org/10.1038/nm1480
131. Tilg H. Diet and intestinal immunity. N Engl J Med 2012; 366:181-3 PMID:22236230 http://dx.doi.org/10.1056/NEJMcibr1113158
132. Gonda TA, Kim Y-I, Salas MC, Gamble MV, Shibata W, Muthupalani S, Sohn KJ, Abrams JA, Fox JG, Wang TC, et al. Folic acid increases global DNA methylation and reduces inflammation to prevent Helicobacter-associated gastric cancer in mice. Gastroenterology 2012; 142:824-833 PMID:22248660 http://dx.doi.org/10.1053/j.gastro.2011.12.058
133. Cameron A, Frirdich E, Huynh S, Parker C T, Gaynor EC. Hyperosmotic stress response of Campylobacter jeju-ni. J Bacteriol 2012; 194:6116-30 PMID:22961853 http://dx.doi.org/10.1128/JB.01409-12
134. Loh J T, Torres VJ, Cover TL. Regulation of Helicobacter pylori cagA expression in response to salt. Cancer Res 2007; 67:4709-15 PMID:17510398 http://dx.doi.org/10.1158/0008-5472.CAN-06-4746
135. Gancz H, Jones KR, Merrell DS. Sodium chloride affects Helicobacter pylori growth and gene expression. J Bacteriol 2008; 190:4100-5 PMID:18375562 http://dx.doi.org/10.1128/JB.01728-07
136. Loh JT, Friedman DB, Piazuelo MB, Bravo LE, Wilson KT, Peek RM Jr., Correa P, Cover TL. Analysis of Helicobacter pylori cagA promoter elements required for salt-induced upregulation of CagA expression. Infect Immun 2012; 80:3094-106 PMID:22710874 http://dx.doi.org/10.1128/IAI.00232-12
137. Loh J T, Shaffer CL, Piazuelo MB, Bravo LE, McClain MS, Correa P, Cover TL. Analysis of cagA in Helicobacter pylori strains from Colombian populations with contrasting gastric cancer risk reveals a biomarker for disease severity. Cancer Epidemiol Biomarkers Prev 2011; 20:2237-49 PMID:21859954 http://dx.doi.org/10.1158/1055-9965.EPI-11-0548
138. Gilbreath JJ, Cody WL, Merrell DS, Hendrixson DR. Change is good: variations in common biological mechanisms in the epsilonproteobacterial genera Campylobacter and Helicobacter. Microbiol Mol Biol Rev 2011; 75:84-132 PMID:21372321 http://dx.doi.org/10.1128/MMBR.00035-10
139. Pich OQ, Merrell DS. The ferric uptake regulator of Helicobacter pylori: a critical player in the battle for iron and colonization of the stomach. Future Microbiol 2013; 8:725-38 PMID:23701330 http://dx.doi.org/10.2217/fmb.13.43
140. Ge R, Sun X. Iron trafficking system in Helicobacter pylori. Biometals 2012; 25:247-58 PMID:22127376 http://dx.doi.org/10.1007/s10534-011-9512-8
141. Whitmire JM, Gancz H, Merrell DS. Balancing the double-edged sword: metal ion homeo-stasis and the ulcer bug. Curr Med Chem 2007; 14:469-78 PMID:17305547 http://dx.doi.org/10.2174/092986707779941069
142. Merrell DS, Thompson LJ, Kim CC, Mitchell H, Tompkins LS, Lee A, Falkow S. Growth phase-dependent response of Helicobacter pylori to iron starvation. Infect Immun 2003; 71:6510-25 PMID:14573673 http://dx.doi.org/10.1128/IAI.71.11.6510-6525.2003
143. Gancz H, Censini S, Merrell DS. Iron and pH homeostasis intersect at the level of Fur regulation in the gastric pathogen Helicobacter pylori. Infect Immun 2006; 74:602-14 PMID:16369017 http://dx.doi.org/10.1128/IAI.74.1.602-614.2006
144. Ernst FD, Bereswill S, Waidner B, Stoof J, Mäder U, Kusters JG, Kuipers EJ, Kist M, van Vliet AH, Homuth G. Transcriptional profiling of Helicobacter pylori Fur-and iron-regulated gene expression. Microbiology 2005; 151:533-46 PMID:15699202 http://dx.doi.org/10.1099/mic.0.27404-0
145. Lee HW, Choe YH, Kim DK, Jung SY, Lee NG. Proteomic analysis of a ferric uptake regulator mutant of Helicobacter pylori: regulation of Helicobacter pylori gene expression by ferric uptake regulator and iron. Proteomics 2004; 4:2014-27 PMID:15221763 http://dx.doi.org/10.1002/pmic.200300740
146. Pich OQ, Carpenter BM, Gilbreath JJ, Merrell DS. Detailed analysis of Helicobacter pylori Fur-regulated promoters reveals a Fur box core sequence and novel Fur-regulated genes. Mol Microbiol 2012; 84:921-41 PMID:22507395 http://dx.doi.org/10.1111/j.1365-2958.2012.08066.x
147. Tan S, Tompkins LS, Amieva MR. Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche. PLoS Pathog 2009; 5:e1000407 PMID:19412339 http://dx.doi.org/10.1371/journal. ppat.1000407
148. Tan S, Noto JM, Romero-Gallo J, Peek RM Jr., Amieva MR. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog 2011; 7:e1002050 PMID:21589900 http://dx.doi.org/10.1371/journal.ppat.1002050